DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Carboplatin (Carboplatin) - Current Clinical Trials

 
 



Carboplatin Related Clinical Trials

Trientine and Carboplatin in Advanced Malignancies [Completed]

BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors [Recruiting]

Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer [Recruiting]

Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) [Recruiting]

Open-label Phase 1b Study of ARQ 092 in Combination With Carboplatin Plus Paclitaxel [Recruiting]

Breast Cancer Treatment Using Weekly Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting [Recruiting]

Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer [Recruiting]

A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies [Terminated]

PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer [Completed]

Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer [Recruiting]

Study of Vemurafenib, Carboplatin, and Paclitaxel [Recruiting]

Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) [Completed]

Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer [Completed]

Melphalan, Carboplatin, and Sodium Thiosulfate for Patients With Central Nervous System (CNS) Embryonal or Germ Cell Tumors [Recruiting]

Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases [Recruiting]

G1T28 (CDK 4/6 Inhibitor) in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) [Recruiting]

Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide for Refractory or Relapsed Aggressive B-Cell Lymphomas [Recruiting]

Validation of an Adjusted Dosing Algorithm of Carboplatin [Not yet recruiting]

Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG) [Completed]

Veliparib and Dinaciclib With or Without Carboplatin in Treating Patients With Advanced Solid Tumors [Recruiting]

A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer [Completed]

Trial Comparing Two Carboplatin Doses in Groups C and D Intraocular Retinoblastoma [Active, not recruiting]

Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Completed]

Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) [Active, not recruiting]

Carboplatin in Treating Patients With Recurrent High-Grade Gliomas [Recruiting]

High-Dose or Low-Dose Vorinostat in Combination With Carboplatin or Paclitaxel in Treating Patients With Advanced Solid Tumors [Active, not recruiting]

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel [Active, not recruiting]

Pegylated Liposomal Doxorubicin and Carboplatin as First Line Treatment for Patients With Advanced Non-small Cell Lung Cancer [Recruiting]

Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma [Completed]

Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer [Withdrawn]

Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery [Recruiting]

A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors [Active, not recruiting]

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer [Completed]

Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers [Recruiting]

Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin [Active, not recruiting]

Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers [Active, not recruiting]

First-line Treatment of Weekly Paclitaxel With Carboplatin and Bevacizumab in Ovarian Cancer [Active, not recruiting]

A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer [Completed]

Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial [Recruiting]

Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer [Completed]

Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC) [Withdrawn]

Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors [Completed]

Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer [Recruiting]

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Recruiting]

Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma [Recruiting]

Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer [Completed]

Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer [Completed]

A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer [Completed]

Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer [Completed]

Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer [Completed]

CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular Retinoblastoma [Completed]

UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors [Completed]

Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer [Completed]

Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases [Completed]

A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) Patients [Completed]

A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer [Completed]

Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer [Completed]

Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer [Completed]

Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme [Recruiting]

Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib [Terminated]

Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer [Completed]

CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC) [Completed]

Phase I Study of TAS-106 in Combo With Carboplatin [Completed]

Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer [Recruiting]

Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary [Completed]

SGI-110 in Combination With Carboplatin in Ovarian Cancer [Active, not recruiting]

A Phase 1B/2 Study of LY2940680 in Combination With Weekly Paclitaxel, Carboplatin, and Radiation in Localized Adenocarcinoma of the Esophagus or Gastroesophageal Junction [Not yet recruiting]

Efficacy Study of AvastinŽ With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer [Completed]

PARP Inhibitor BMN-673, Carboplatin, and Paclitaxel in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Not yet recruiting]

Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer [Active, not recruiting]

Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer [Active, not recruiting]

Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer [Active, not recruiting]

Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection [Recruiting]

Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment [Recruiting]

Neoadjuvant Carboplatin and Docetaxel in TNBC [Recruiting]

Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer [Active, not recruiting]

Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer [Completed]

Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC [Recruiting]

PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung Cancer [Active, not recruiting]

Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer [Recruiting]

Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung Cancer [Completed]

Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Recruiting]

Carboplatin and Bevacizumab for Recurrent Ependymoma [Recruiting]

Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC) [Recruiting]

Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer [Recruiting]

PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer [Completed]

Carboplatin/Nab-Paclitaxel and MK-3475 in NSCLC [Recruiting]

Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer [Terminated]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017